Factor V (Leiden) Mutation Analysis
Use
Factor V (Leiden) Mutation Analysis detects the presence or absence of the factor V Leiden mutation (also known as R506Q or G1691A), which is a hereditary risk factor for venous thrombophilia due to activated protein C resistance. It is intended for individuals with personal or family history of thromboembolic events to evaluate inherited thrombophilia risk.
Special Instructions
This test was developed and analytically validated by Quest Diagnostics under CLIA regulations. It is not FDA cleared or approved. Refer to Quest Diagnostics Nichols Institute for performance characteristics.
Limitations
Not provided.
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 21668-9
- 21667-1
Result Turnaround Time
6 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
4 mL preferred, 3 mL minimum
Minimum Volume
3 mL
Container
EDTA (lavender-top) tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 8 days |
| Refrigerated | 8 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant